| 1 | innovation in emerging medical | | | | | | | 2 | 0.57% |
| 2 | accelerate innovation in emerging | | | | | | | 2 | 0.57% |
| 3 | attractive proposition for the | | | | | | | 1 | 0.29% |
| 4 | of typical medtech and | | | | | | | 1 | 0.29% |
| 5 | combination of typical medtech | | | | | | | 1 | 0.29% |
| 6 | the combination of typical | | | | | | | 1 | 0.29% |
| 7 | industry the combination of | | | | | | | 1 | 0.29% |
| 8 | proposition for the european | | | | | | | 1 | 0.29% |
| 9 | home about platforms implantable | | | | | | | 1 | 0.29% |
| 10 | typical medtech and pharma | | | | | | | 1 | 0.29% |
| 11 | are an attractive proposition | | | | | | | 1 | 0.29% |
| 12 | markets are an attractive | | | | | | | 1 | 0.29% |
| 13 | volume markets are an | | | | | | | 1 | 0.29% |
| 14 | high volume markets are | | | | | | | 1 | 0.29% |
| 15 | to high volume markets | | | | | | | 1 | 0.29% |
| 16 | the prospect of medium | | | | | | | 1 | 0.29% |
| 17 | an attractive proposition for | | | | | | | 1 | 0.29% |
| 18 | medtech and pharma applications | | | | | | | 1 | 0.29% |
| 19 | applications with the prospect | | | | | | | 1 | 0.29% |
| 20 | emerging medical domains addressed | | | | | | | 1 | 0.29% |
| 21 | ip moving from the | | | | | | | 1 | 0.29% |
| 22 | moore4medical with value and | | | | | | | 1 | 0.29% |
| 23 | in moore4medical with value | | | | | | | 1 | 0.29% |
| 24 | addressed in moore4medical with | | | | | | | 1 | 0.29% |
| 25 | domains addressed in moore4medical | | | | | | | 1 | 0.29% |
| 26 | medical domains addressed in | | | | | | | 1 | 0.29% |
| 27 | the emerging medical domains | | | | | | | 1 | 0.29% |
| 28 | with an open platform | | | | | | | 1 | 0.29% |
| 29 | enhance the competitiveness for | | | | | | | 1 | 0.29% |
| 30 | will enhance the competitiveness | | | | | | | 1 | 0.29% |
| 31 | approach will enhance the | | | | | | | 1 | 0.29% |
| 32 | platform approach will enhance | | | | | | | 1 | 0.29% |
| 33 | open platform approach will | | | | | | | 1 | 0.29% |
| 34 | an open platform approach | | | | | | | 1 | 0.29% |
| 35 | with the prospect of | | | | | | | 1 | 0.29% |
| 36 | multiple applications with the | | | | | | | 1 | 0.29% |
| 37 | from the technology level | | | | | | | 1 | 0.29% |
| 38 | 12 countries who will | | | | | | | 1 | 0.29% |
| 39 | technology platforms for these | | | | | | | 1 | 0.29% |
| 40 | open technology platforms for | | | | | | | 1 | 0.29% |